Preventive Maintenance and Calibration for Intercept Pathogen Reduction Systems at U.S. Naval Hospital Okinawa

The Defense Health Agency awarded a firm-fixed price, sole source contract to Cerus Corporation on January 28, 2025, for the preventive maintenance and calibration of two Government-owned Intercept Pathogen Reduction Systems (INT 100-60) at the U.S. Naval Hospital Okinawa in Japan. The total contract value is $68,398.00, covering a base period from February 9, 2025, to February 8, 2026, with two confirmed option periods extending through February 8, 2028, and potential additional options through 2030. The award was justified under FAR 13.106-1(b)(1)(i) due to the proprietary nature of the equipment and the requirement for OEM-trained personnel to ensure system integrity and FDA compliance. The scope of work requires semi-annual on-site inspections, calibrations, and safety checks performed during regular working hours. Key deliverables include signed service slips and detailed electronic service reports submitted within 24 hours of completion. The contractor must provide 48-hour advance notification prior to site visits and is responsible for all labor, travel, and mileage costs. While routine maintenance is covered, the contract excludes replacement parts beyond normal wear and repairs resulting from government misuse or unauthorized modifications. Inspection and formal acceptance of services are conducted by the receiving officer at the place of performance in Camp Foster, Okinawa.